Galactagogue Use in Lactating Women With Low Milk Supply

Winthrop University120 enrolled

Overview

This study aims to determine whether a 20-day supplement with either Oat Mama Lactation Supplement, moringa, or shatavari has any impact on milk production through an increase in serum prolactin levels when compared to the placebo group. This data will be used to determine if clinical recommendations can be made for the use of the studied supplements in increasing milk supply.

This study will be a double-blind randomized control trial where eligible participants will be randomized into one of four treatment groups: Oat Mama Lactation Supplement (O), moringa supplement (M), shatavari supplement (S), or control (C). All participants will receive a supplement or placebo for consumption throughout the 20-day trial period, and all participants will receive support from a lactation consultant once per week to receive appropriate guidance for increasing milk supply. 24-hour milk output will be recorded on day 1, 10, and 20 using either pre- and post-feeding weights, 24-hour pump output, or a combination of both. Additionally, blood samples will be taken on day 1, 10, and 20 and serum will be isolated for later analysis of serum prolactin levels.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

120

Conditions

Breast Milk Expression

Interventions

Galactagogue Supplement for Treatment of Low Milk SupplyDIETARY_SUPPLEMENT

Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Participants in the study must: * Be struggling with diagnosed or perceived low milk supply * Be willing to consume a randomly assigned galactagogue or placebo supplement * Be willing to provide a blood sample at each lactation consult (day 1, 10, 20) * Be willing to provide 24-hour expressed milk volume either using pre- and post-feed weights, total pump output, or a combination of both on day 1, 10, and 20 Exclusion Criteria: Participants will be excluded if: * They have a history of breast reduction * They have a history of utilizing in vitro fertilization * They are not a biological female with mammary glands present for producing milk * They have consumed galactagogues with the intention of increasing their milk supply during the current lactation cycle * They are under age 18 or above age 39

Locations (1)

Winthrop University

Rock Hill, South Carolina, United States

RECRUITING

Outcomes

Primary Outcomes

Change in Breast Milk Supply

Change in breast milk supply will be evaluated using 24-hour breast milk expression volume

Time frame: Intervention will last 20 days and 24-hour breast milk expression volume will be measured on day 1, 10, and 20 and used to calculate change in 24-hour breast milk expression volume over the trial period

Change in Serum Prolactin

Change in serum prolactin levels will be evaluated by taking blood samples on day 1, 10, and 20 and measuring serum prolactin using a human serum prolactin ELISA kit

Time frame: Intervention will last 20 days and blood samples will be taken on day 1, 10, am 20 and change in serum prolactin will be measured using a human serum prolactin ELISA kit

Central Contacts

Hope K Lima, PhD

CONTACT

803-323-4540 limah@winthrop.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.